Gut Bacteria Sugars Trigger Immune Attacks Linked to ALS and Frontotemporal Dementia
Case Western Reserve study finds gut bacteria sugars trigger immune attacks linked to ALS and frontotemporal dementia in C9orf72-deficient individuals.
Read More
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
Health
Mississippi Health Chief Dan Edney Declines CDC Director Nomination
Mississippi State Health Officer Dr. Daniel P. Edney declined the nomination to become director of the CDC, officials confirmed Thursday.
Read More
Plant Compounds Like Menthol and Capsaicin Target Chronic Inflammation in Diabetes and Cancer
Studies show plant compounds like menthol and capsaicin reduce chronic inflammation in diabetes and cancer by targeting cellular pathways.
Read More
Hydrogen Sulfide Gas from CSE Protein Emerges as Potential Alzheimer’s Treatment Target
Johns Hopkins researchers identify CSE enzyme and hydrogen sulfide as potential targets to prevent Tau protein-related Alzheimer’s progression.
Read More
Russian Bots, Kremlin Agitprop, and Meta’s Blind Eye: The Disinformation War Over Hungary’s 2026 Election
As Hungary votes April 12, Russian GRU operatives, bot networks, and AI-generated deepfakes flood Facebook while Meta looks the other way. A comprehensive investigation into the Kremlin’s election interference machine and Zuckerberg’s complicity.
Read More
Studies Confirm Direct Oral Challenge Safely Delabels Penicillin Allergies in Hospitals
Studies show direct oral challenge safely removes penicillin allergies in hospitals, increasing penicillin use 13-fold within 90 days.
Read More
Stopping Ozempic or Wegovy Reverses Cardiovascular Benefits, New Study Warns
A study finds stopping Ozempic or Wegovy for six months or more reverses cardiovascular benefits in type 2 diabetes patients.
Read More
UK Biobank Study: Highest Physical Activity Levels Cut Cancer Risk by 26% Across 13 Types
A UK Biobank study found that highest physical activity levels reduce risk of 13 cancer types by 26%, based on accelerometer data.
Read More
Novo Nordisk’s Oral Wegovy Gains FDA Approval, 25mg Semaglutide Tablet Launches for Weight Management
The FDA approved Novo Nordisk’s 25 mg oral Wegovy semaglutide tablet for adult weight management, launching in January 2026.
Read More
DNA-Based ‘Smart’ Drug Targets Cancer Cells with Precision, Activates Only on Tumor Markers
Researchers developed a DNA-based drug that activates only in cancer cells expressing two tumor markers, improving targeted treatment precision.
Read More